| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/26/2000 | EP0973819A1 Non-antigenic branched polymer conjugates |
| 01/26/2000 | EP0973818A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same |
| 01/26/2000 | EP0973798A1 Inhibition of major groove dna binding proteins by modified polyamides |
| 01/26/2000 | EP0973794A1 Netrin receptors |
| 01/26/2000 | EP0973793A1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same |
| 01/26/2000 | EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/26/2000 | EP0973791A2 Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olifinic double bonds |
| 01/26/2000 | EP0973790A1 Estra-5(10),7-dienes with estrogenic activity |
| 01/26/2000 | EP0973789A1 Novel phosphate compounds and their use as medicaments |
| 01/26/2000 | EP0973780A1 Antibacterial substituted 7-acylamino -3-(methylhydrazono) methyl-cephalosporins and intermediates |
| 01/26/2000 | EP0973779A1 Crystalline amine salt of cefdinir |
| 01/26/2000 | EP0973778A1 4,5,6,7-TETRAHYDRO-THIENO 3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE |
| 01/26/2000 | EP0973777A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 01/26/2000 | EP0973775A1 Pyrolopyrrolone derivatives |
| 01/26/2000 | EP0973774A1 1,5-dihydro-pyrazolo 3,4-d]-pyrimidinone derivatives |
| 01/26/2000 | EP0973773A1 Pyrimido-isoquinoline compounds with anticonvulsive action |
| 01/26/2000 | EP0973772A1 Compounds |
| 01/26/2000 | EP0973768A1 Azole compounds, their production and their use |
| 01/26/2000 | EP0973767A1 Indazoles of cyclic ureas useful as hiv protease inhibitors |
| 01/26/2000 | EP0973766A1 Quinoxalinediones |
| 01/26/2000 | EP0973763A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 01/26/2000 | EP0973760A1 Kodaistatins a, b, c and d, a process for their production and their use |
| 01/26/2000 | EP0973756A1 Thiodepsipeptides for combating endoparasites and a method for producing the same |
| 01/26/2000 | EP0973753A2 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors |
| 01/26/2000 | EP0973750A1 Substituted benzimidazoles and their use for treating retroviral infection |
| 01/26/2000 | EP0973749A1 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists |
| 01/26/2000 | EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/26/2000 | EP0973746A1 Substituted 3-cyano quinolines |
| 01/26/2000 | EP0973744A1 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia |
| 01/26/2000 | EP0973743A1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
| 01/26/2000 | EP0973741A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 01/26/2000 | EP0973740A1 Design, synthesis and use of specific polyamide dna-binding ligands |
| 01/26/2000 | EP0973738A1 Novel heterocyclic compounds |
| 01/26/2000 | EP0973735A2 Polyaromatic antiviral compositions |
| 01/26/2000 | EP0973733A1 Bis-sulfonomides hydroxamic acids as mmp inhibitors |
| 01/26/2000 | EP0973732A2 Aryl- or heteroarylsulfonamide substituted hydroxamic acid derivatives, process for their preparation and their use as pharmaceuticals |
| 01/26/2000 | EP0973731A1 Hydroxamic acid derivatives |
| 01/26/2000 | EP0973730A1 Calcilytic compounds |
| 01/26/2000 | EP0973727A2 Activated iododerivatives for the treatment of cancer and aids |
| 01/26/2000 | EP0973725A2 New 1,7,7-trimethyl-bicyclo 2.2.1]heptane derivatives |
| 01/26/2000 | EP0973705A1 Chromatographic enantiomer separation of lactones |
| 01/26/2000 | EP0973563A1 System, method and composition for dialysis and shock treatment |
| 01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
| 01/26/2000 | EP0973534A1 Pharmaceutical compositions having appetite suppressant activity |
| 01/26/2000 | EP0973533A1 Methods for inhibiting bacterial cytotoxicity |
| 01/26/2000 | EP0973531A1 Facilitation of wound healing with cm101/gbs toxin |
| 01/26/2000 | EP0973527A1 Extended release formulations of erythromycin derivatives |
| 01/26/2000 | EP0973526A1 Sulfated oligosaccharides having anticoagulant/antithrombotic activity |
| 01/26/2000 | EP0973525A1 Oral compositions containing fluocinonide |
| 01/26/2000 | EP0973524A1 Cosmetic or dermatological use of 7-hydroxylated steroids |
| 01/26/2000 | EP0973523A1 Anti-microbial product |
| 01/26/2000 | EP0973522A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 01/26/2000 | EP0973521A1 Cyclopentylxanthine derivatives for use in the treatment of cystic fibrosis |
| 01/26/2000 | EP0973520A1 Granules comprising clavulanate and one or more excipients |
| 01/26/2000 | EP0973519A1 Inclusion complexes in aqueous solution |
| 01/26/2000 | EP0973517A1 Antithrombotic agents |
| 01/26/2000 | EP0973516A1 Use of halo and/or nitro-substituted flavonoids as anxyolitics |
| 01/26/2000 | EP0973515A1 Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
| 01/26/2000 | EP0973514A1 $i(IN VIVO) POLYMERIZABLE OPHTHALMIC COMPOSITIONS |
| 01/26/2000 | EP0973513A1 Compositions and methods for treating bone deficit conditions |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973511A1 Use of sibutramine analogues to lower lipid levels |
| 01/26/2000 | EP0973510A1 Use of amantadine for treatment of hepatitis c |
| 01/26/2000 | EP0973508A1 Pharmaceutical tablet of amiodarone salt |
| 01/26/2000 | EP0973505A1 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/26/2000 | EP0973504A1 Hemostatic aerosol composition |
| 01/26/2000 | EP0973501A2 Aqueous suspension for nasal administration of loteprednol |
| 01/26/2000 | EP0973500A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma |
| 01/26/2000 | EP0973499A1 Diffusional implantable delivery system |
| 01/26/2000 | EP0973498A1 Gastrointestinal mucosa-adherent pharmaceutical composition |
| 01/26/2000 | EP0973461A1 Method of treatment of migraine |
| 01/26/2000 | EP0973396A1 A method of treating cancer |
| 01/26/2000 | EP0973394A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0973390A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease |
| 01/26/2000 | EP0927030A4 Use of aryl n-substituted carboxamides to kill tumors |
| 01/26/2000 | EP0835251B1 Process for the production of lipoic acid |
| 01/26/2000 | EP0820307A4 Increasing the hdl level and the hdl/ldl ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids |
| 01/26/2000 | EP0791006B1 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 01/26/2000 | EP0778834B1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 01/26/2000 | EP0763016B1 Compositions and methods for treating mast-cell mediated conditions |
| 01/26/2000 | EP0758895B1 Sublingual dosage forms containing apomorphine for use in the treatment of erectile dysfunction |
| 01/26/2000 | EP0722316B1 New emulsion formulation |
| 01/26/2000 | EP0686145B1 New compounds |
| 01/26/2000 | EP0670839B1 Process for the preparation of 9-amino camptothecin |
| 01/26/2000 | EP0650484B1 Endothelin receptor antagonists |
| 01/26/2000 | EP0626943B1 Bistriazenes as chemotherapeutic agents |
| 01/26/2000 | CN1242773A Ticyclic carbapenem compound |
| 01/26/2000 | CN1242772A Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine |
| 01/26/2000 | CN1242768A Antithrombotic organic nitrates |
| 01/26/2000 | CN1242705A Granules comprising clavulanate and one or more excipients |
| 01/26/2000 | CN1242704A Tabletted prepn. |
| 01/26/2000 | CN1242703A Chewing gum contg. colloidal bismuth subcitrate |
| 01/26/2000 | CN1242701A Compositions contg. antifungal and cationic agent |
| 01/26/2000 | CN1242373A Novel arabinosyladenine derivatives |
| 01/26/2000 | CN1242368A New imidazotriazolopyrimidines, processes for preparing them and their use as pharmaceutical compositions |
| 01/26/2000 | CN1242367A Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole] |
| 01/26/2000 | CN1242366A Diaza-spiro [3,5] nonane derivatives |
| 01/26/2000 | CN1242365A Azole alcohol derivatives, prepn. method and pharmaceutical use thereof |
| 01/26/2000 | CN1242364A Red sage root extract for treating peptic gastric ulcer, and process for preparing same |